Hospitalized Pregnant COVID-19 Patients May Not Have Increased Mortality Risk
Less than 1% of the pregnant women died during the study period, compared to 3.5% of the non-pregnant patients.
COVID-19 Variant Found in India May be More Transmissible
The worsening situation in India has raised concerns about the novel variant of the virus and its transmissibility.
Adverse Outcomes for Newborns of Mothers with COVID-19 Associated with Social Vulnerability, Preterm Birth
Maternal social vulnerability and preterm birth were associated with higher risk of adverse health outcomes among infants born to mothers with SARS-CoV-2 infection, a new study found.
Monitoring Asymptomatic COVID-19 Cases in Children Could Reduce Transmission
In a simulated model of vaccinations across age groups, investigators determined that asymptomatic infections in children will impact transmission of COVID-19 even among adults.
FDA Expands Pfizer-BioNTech COVID-19 Vaccine for Adolescents 12-15 Years Old
The first US COVID-19 vaccine breaks ground again, as the first authorized for patients as young as 12 years old.
Ebola Outbreak in DRC Declared Over
The Democratic Republic of the Congo (DRC) reached 42 days without a new case. Guinea, however, has not officially declared its outbreak over yet.
EU Turning Away From AstraZeneca Vaccine, Putting Hope in Pfizer-BioNTech
Malaysia begins nationwide lockdown due to third wave of the pandemic.
Novavax Combination Vaccine Shows Positive Preclinical Results
NanoFlu/NVX-CoV2373 elicited functional influenza and COVID-19 antibodies in ferrets 2 weeks after vaccination.
Inovio Announces Results from its Phase 2 COVID-19 Vaccine Trial
Investigators report the vaccine demonstrated it was safe, well-tolerated, and immunogenic in all age groups.
The COVID-19 Pandemic and Cancer Screenings
Long-term implications of the pandemic will be felt for years to come. Cancer screenings, for example, were down in the early months of the pandemic in the United States and raise concerns about getting diagnosed and treated.
New Anti-Tuberculosis Regimen Cures 2 Months Earlier
Rifapentine-moxifloxacin based anti-tuberculosis regimen shortened the conventional six-month course of treatment to four.
Public Health Watch: Military Study Suggests SARS-CoV-2 Immunity May Last Up to 1 Year in Some
Protection from “natural infection” may last longer in older adults, authors say.
Exercise May Aid in Recovery of Long Lasting COVID-19 Symptoms
Patients who completed a 6 week rehabilitation program showed statistically significant improvement in exercise capacity, overall wellbeing and cognition.
Novavax and Gavi Announce Purchase Agreement for COVAX Facility
Novavax plans to deliver approximately 350 million doses to COVAX during the third quarter of 2021.
China’s Sinopharm COVID-19 Vaccine Approved by WHO
The vaccine will now be included in WHO’s COVAX initiative, which is providing greater and more equitable access to vaccines around the world.
High COVID-19 Vaccine Coverage by Summer Could Prevent Millions of Cases
Reaching a vaccination rate of 50% by July of 2021 could prevent 5.8 million cases and 215,790 hospitalizations.
Pfizer-BioNTech Applying for FDA BLA for Their COVID-19 Vaccine
The companies are seeking approval for anyone aged 16 and above.
Machine Learning Improves Prediction of Sepsis after Stem Cell Transplant
Machine learning improves prediction of bacterial sepsis among immunocompromised recipients of stem cell transplant.
Moderna COVID-19 Vaccine is 96% Efficacious in Pediatric Population
Company plans to initiate a rolling submission for US Food and Drug Administration (FDA) Biologics License Application (BLA) this month for the vaccine.
One Third of Hospitalized COVID-19 Patients Have Changes in Lungs a Year After Infection
While the majority of COVID-19 patients made a full recovery, some still showed signs of reduced lung functioning during the study period.
Long-Acting Injectable May be Potential Therapy for COVID-19
Niclosamide, a common therapy for tapeworm infestation, has shown in lab studies to be highly effective against SARS-CoV-2.
COVID-19 Vaccine Booster Dose Increases Immune Response to SARS-CoV-2, 2 Variants
Moderna reports data demonstrating a single 50 µg shot of its mRNA-1273 or mRNA-1273.351 booster shot increased neutralizing titers against SARS-CoV-2, as well as the South African and Brazilian variants.
Pfizer-BioNTech COVID-19 Vaccine Significantly Prevents Infection, Severe Disease in Israel
New real-world research suggest the vaccine may help provide control of the pandemic virus.
Novavax Reports Effectiveness of its COVID-19 Vaccine Against South African Variant
Amongst HIV negative participants, the vaccine demonstrated a 51% efficaciousness against B.1.351.
Biden Administration Announces Support for Lifting Patent Protections on COVID-19 Vaccines
As countries like India and those in South America continue to struggle, the loosening of protections will help in their fight against the virus.
HEPA Filters Reduce Airborne Particles During Vigorous Exercise
A portable filter was shown to reduce the amount of exercise generated aerosols by 96%.
Can Surfaces be Designed to Help Mitigate COVID-19 Spread?
A surface with an optimal combination of wettability and physical texture can help reduce viral transmission.
Vancomycin AUC Implementation in Resource-Limited Settings and its Associated Difficulties
The latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.
Applying UV Light to Common Disinfectants Could Help Them Fight COVID-19
Ultraviolet-C light is able to neutralize the harmful levels of benzalkonium chloride found in many disinfectants, making them safer to use.
Protein “Signature” of Severe COVID-19 Identified
The analysis identified over 250 severity associated proteins that can help to explain varying cases of disease in patients.